Status:
COMPLETED
Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Cutaneous T Cell Lymphoma
Graft Versus Host Disease
Eligibility:
All Genders
18+ years
Brief Summary
Extracorporeal Photopheresis (ECP) is a form of apheresis and photodynamic therapy in which the peripheral blood is treated with 8-methoxypsoralen, which is then activated with UV light. ECP is curren...
Detailed Description
The investigators intend to report outcomes from the inception of this procedure at Dartmouth-Hitchcock Medical Center (DHMC) in May 2008 through 9/30/11. Additionally, the investigators would like to...
Eligibility Criteria
Inclusion
- Patients who receive Extracorporeal Photopheresis treatment
- Treated at Dartmouth-Hitchcock Medical Center
- Must be 18 years or older
Exclusion
- \- None specified
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 6 2015
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01460914
Start Date
October 1 2011
End Date
January 6 2015
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756